Therapeutic options for essential thrombocythemia and polycythemia vera

被引：13
|
作者：
Solberg, LA [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Mayo Med Sch, Jacksonville, FL USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期
关键词：
D O I：
10.1053/sonc.2002.33755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 15
页数：6
相关论文
共 50 条
  • [31] Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia
    Dingli D.
    Tefferi A.
    Current Hematologic Malignancy Reports, 2006, 1 (2) : 69 - 74
  • [32] Platelet activation and inhibition in polycythemia vera and essential thrombocythemia
    Patrono, Carlo
    Rocca, Bianca
    De Stefano, Valerio
    BLOOD, 2013, 121 (10) : 1701 - 1711
  • [33] Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
    Reikvam, H.
    Tiu, R. V.
    LEUKEMIA, 2012, 26 (04) : 563 - 571
  • [34] Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia
    Johansson, P
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (03): : 171 - 173
  • [35] Emerging agents and regimens for polycythemia vera and essential thrombocythemia
    Rory M. Shallis
    Nikolai A. Podoltsev
    Biomarker Research, 9
  • [36] Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice
    Tefferi, Ayalew
    Barbui, Tiziano
    MAYO CLINIC PROCEEDINGS, 2015, 90 (09) : 1283 - 1293
  • [37] Is myocardial infarction as frequent in essential thrombocythemia as in polycythemia vera?
    Randi, ML
    Rossi, C
    Zerbinati, P
    Girolami, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS182 - PS182
  • [38] Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
    Silver, Richard T.
    Kiladjian, Jean-Jacques
    Hasselbalch, Hans Carl
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (01) : 49 - 58
  • [39] Evidence and expertise in the management of polycythemia vera and essential thrombocythemia
    Finazzi, G.
    Barbui, T.
    LEUKEMIA, 2008, 22 (08) : 1494 - 1502
  • [40] Evidence and expertise in the management of polycythemia vera and essential thrombocythemia
    G Finazzi
    T Barbui
    Leukemia, 2008, 22 : 1494 - 1502
12345